Myopia

The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.

The upgraded Myopia Software Package offers comprehensive screening, ortho-k fitting, and myopia management in one device.

The study evaluated 13 teenagers and young adults who had high myopia (−6.50 to −9.25 D).

Visual acuity remains an important indication of ocular and visual health.

The 2025 Myopia Research Grant will comprise of 3 awards of $500,000 each.

From eye drops to novel treatments, it’s time to assess all options for improving patients’ visual acuity.

The updated range of lenses feature expanded negative and cylindrical powers, thinner edge thickness, and wider frame options.

The longitudinal study found that visual function and BCVA decreased with an increasing incidence rate of moderate and severe visual impairment for patients with high myopia.

Following the switch from multifocal to single-vision contact lenses, axial elongation increased by 0.03 mm/year, and myopia progressed at a rate of −0.17 D annually after switching to single-vision lenses.

With this addition, Zeiss completes the Corneal Refractive Workflow, which already includes Visumax 800 and SMILE pro.

The educational resources is now being used in 64% of the world's countries, with the US, the United Kingdom, Malaysia, India, Australia, and Canada as the most frequent users.

Model simulations conducted in part to assess net monetary benefit found that comprehensive eye examinations every 3 years were more cost effective than less frequent examinations.

Trending topics and milestone stories from our year in ophthalmology.

Key takeaways from the past year that can help optometrists look ahead to 2025.

The research findings supported the hypothesis that a mild reduction in retinal contrast can slow myopia progression in young children.

New long-term findings illuminate the future of DIMS spectacle lenses.

A new classification system helps patients reach informed decisions.

Increased choroidal thickness also was seen in children treated with 1% atropine for 1 week or 0.01% atropine for less than 8 weeks.

Six topics were assessed in the report, including global data on myopia prevalence, technology, environmental and genetic contributions to myopia onset and progression, and mechanistic causes of myopia pathogenesis, among others.

Understanding and balancing digital exposure in children can reduce myopia progression.

By alternating the focus area—or the clear zone of the lens—and defocus area—the honeycomb-shaped segment of the lens—the spectacle lenses achieve clear vision and manage myopia progression.

Pediatric optometrist Dr. Magdalena Stec highlights effective treatment options and practical advice for parents to help manage and control myopia in their kids.

Adam S. Wenick, MD, PhD, discussed myopia interventions across the lifespan at EyeCon 2024, covering treatments, complications, and prevention strategies.

Brianna Rhue, OD, FAAO, FSLS, shares her passion for myopia management and control at this year's Vision Expo West.

An inside look into a retrospective study conducted from 2019 to 2023 that aimed to assess the effectiveness of treatment and prevention of the progression of uncomplicated acquired myopia through physiotherapeutic methods.

Resources available during the month include a seminar series and course bundles.

Living a long life and preserving eye health can go hand in hand.

The strike force involves more than a dozen medical and nonmedical professionals to help bridge the gap between failed vision screenings and follow-up examinations.

Exploring myopia control treatment efficacy does not demand clinical complexity.